National Institute of Allergy and Infectious Diseases; Notice of Meetings, 78986-78987 [2022-27955]
Download as PDF
<![CDATA[
78986
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
Dated: December 19, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–27918 Filed 12–22–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
TKELLEY on DSK125TN23PROD with NOTICE
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below and held as
a virtual meeting. Individuals who plan
to participate and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 1–2, 2023.
Open: February 1, 2023, 1:00 p.m. to 5:30
p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Activities; and Administrative
and Program Developments.
Open session will be videocast from this
link: https://videocast.nih.gov/.
Closed: February 2, 2023, 1:00 p.m. to 5:30
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Rockville, MD 20852 (Virtual Meeting).
Contact Person: Robert Finkelstein, Ph.D.
Director of Extramural Research, National
Institute of Neurological, Disorders and
Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248, finkelsr@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
the statement to the Contact Person listed on
this notice at least 10 days in advance of the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: December 19, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–27958 Filed 12–22–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meeting will be open to the
public. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: January 30, 2023.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Acting
Director.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Room 4F30, 5601 Fishers Lane,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892, 301–496–7291, poeky@mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Allergy, Immunology and Transplantation
Subcommittee.
Date: January 30, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50 Bethesda, MD
20892, 301–496–7291, poeky@mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Microbiology and Infectious Diseases
Subcommittee.
Date: January 30, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892, 301–496–7291, poeky@mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: January 30, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
E:\FR\FM\23DEN1.SGM
23DEN1
78987
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and
Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892, 301–496–7291, poeky@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice at least 10 days in advance of the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaid.nih.gov/about/advisory-council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 19, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–27955 Filed 12–22–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request: National Institute
on Drug Abuse (NIDA) Summer
Research Internship Program
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
displays a currently valid OMB control
number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: National
Institute on Drug Abuse (NIDA) Summer
Research Internship Program—0925–
0738—expiration date, 12/31/2022,
EXTENSION, National Institute on Drug
Abuse (NIDA), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The purpose of the proposed
information is for the selection of
interns for the continuing NIDA
Summer Research Internship Program.
This request is to allow NIDA to collect
information from applicants in order to
meet the goals of the program and IC
mission. Applicant eligibility for this
program is open to those 18 and over in
the year of application per NIH policy
document 2022 Summer Research
Internship Program (NIDA–SRIP) Policy.
NIDA will request clearance for any
additional forms should new programs
be introduced in the future.
The information ensures that students
applying to this program meet basic
eligibility requirements; indicates their
interest in substance abuse research,
future career goals, and, if selected for
the program, what research they prefer
to conduct. The information also
enables decision-making regarding
which applicants will be selected for
internships. In each case, completing
the application is voluntary, but in
order to receive due consideration, the
prospective applicant must complete all
fields required by the program.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
300.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Wilson
Compton, Acting Director, Office of
Research Training, Diversity and
Disparities, 3WFN, 11601 Landsdown
St., Room 09D18, North Bethesda,
Maryland, 20892 or call non-toll-free
number (301) 443–6480 or Email your
request, including your address, to:
Wilson.Compton@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on October 21, 2022, page
64068 (87 FR 64068) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
The National Institute on Drug Abuse
(NIDA), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
ADDRESSES:
TKELLEY on DSK125TN23PROD with NOTICE
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hour
Form name
Type of respondent
Summer Internship ............................
Individuals—household ....................
300
1
1
300
Total ...........................................
...........................................................
........................
300
........................
300
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 87, Number 246 (Friday, December 23, 2022)]
[Notices]
[Pages 78986-78987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27955]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meeting will be open to the public. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov). Individuals who need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: January 30, 2023.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Acting Director.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Room 4F30, 5601 Fishers Lane,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division
of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 4F50, Bethesda, MD 20892, 301-496-7291,
[email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Allergy, Immunology and Transplantation
Subcommittee.
Date: January 30, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division
of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 4F50 Bethesda, MD 20892, 301-496-7291,
[email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
Date: January 30, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division
of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 4F50, Bethesda, MD 20892, 301-496-7291,
[email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council, Acquired Immunodeficiency Syndrome Subcommittee.
Date: January 30, 2023.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of
[[Page 78987]]
Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual
Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4F30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division
of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 4F50, Bethesda, MD 20892, 301-496-7291,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice at least 10 days in advance of the meeting. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
Information is also available on the Institute's/Center's home
page: https://www.niaid.nih.gov/about/advisory-council, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 19, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-27955 Filed 12-22-22; 8:45 am]
BILLING CODE 4140-01-P
